文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

医院监测可预测越南社区肺炎链球菌抗生素耐药性

Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

本研究比较越南胡志明市社区儿童鼻咽部肺炎链球菌分离株(ViPP试验,234份拭子)与全国医院SOAR监测数据,发现社区菌株多重耐药率高达94.4%,且多种抗生素非敏感率与医院数据相似,提示医院监测数据可估算社区耐药状况。

要点

  • 社区儿童肺炎链球菌多重耐药率极高(94.4%)。
  • 青霉素非敏感率达93.6%(口服非脑膜炎折点)。
  • 医院SOAR监测数据与社区ViPP数据多种抗生素非敏感率相似。

核心结论

  • 社区携带的肺炎链球菌中多重耐药比例极高。
  • 尽管ViPP与SOAR人群人口学差异大,多种抗生素非敏感率仍相当。
  • 医院抗生素敏感性数据经一定条件可反映幼童社区肺炎链球菌非敏感状况。

研究设计与样本

  • ViPP为肺炎链球菌结合疫苗试验,采集12月龄参与者234份鼻咽拭子分离肺炎链球菌。
  • 采用CLSI方法进行抗生素敏感性试验,并与全国SOAR医院监测数据比较。

主要发现

  • 青霉素非敏感(口服非脑膜炎折点)占肺炎链球菌阳性ViPP拭子的93.6%。
  • 红霉素、甲氧苄啶/磺胺甲噁唑、克林霉素和四环素非敏感率均超过79%。
  • 多重耐药(对三类及以上抗生素非敏感)占94.4%的拭子。
  • 头孢曲松(非脑膜炎折点)、氧氟沙星和万古霉素耐药率低或未检出。
  • ViPP与SOAR多种抗生素非敏感率相似。

关键数值与推荐

  • 青霉素非敏感判定采用口服、非脑膜炎折点,占比93.6%。
  • 多重耐药定义为对三类及以上抗生素非敏感,占比94.4%。

临床怎么用

  • 越南幼童肺炎链球菌经验性治疗需考虑极高多重耐药率。
  • 医院抗生素敏感性监测数据可辅助社区抗生素处方决策。
  • 需结合当地监测支持抗生素管理策略。

局限性

  • ViPP与SOAR人群人口学特征差异大,比较需谨慎。
  • 仅基于12月龄儿童鼻咽部携带菌株,非侵袭性疾病分离株。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In Vietnam, Streptococcus pneumoniae is a leading cause of disease, including meningitis. Antibiotics are available without physician prescription at community pharmacies and rates of antibiotic non-susceptibility are high. Appropriate treatment and antibiotic stewardship need to be informed by surveillance data. OBJECTIVES: To report community-based pneumococcal antibiotic susceptibility testing data from children enrolled in a pneumococcal conjugate vaccine trial in Ho Chi Minh City [the Vietnam Pneumococcal Project (ViPP)] and compare these with published hospital-based data from the nationwide Survey of Antibiotic Resistance (SOAR) to determine whether hospital surveillance data provide an informative estimate of circulating pneumococcal resistance. METHODS: Pneumococcal isolates from 234 nasopharyngeal swabs collected from ViPP participants at 12 months of age underwent antibiotic susceptibility testing using CLSI methods and the data were compared with SOAR data. RESULTS: Antibiotic susceptibility testing identified penicillin-non-susceptible pneumococci in 93.6% of pneumococcus-positive ViPP swabs (oral, non-meningitis breakpoints). Non-susceptibility to erythromycin, trimethoprim/sulfamethoxazole, clindamycin and tetracycline also exceeded 79%. MDR, defined as non-susceptibility to three or more classes of antibiotic, was common (94.4% of swabs). Low or no resistance was detected for ceftriaxone (non-meningitis breakpoints), ofloxacin and vancomycin. Antibiotic non-susceptibility rates in ViPP and SOAR were similar for several antibiotics tested. CONCLUSIONS: A very high proportion of pneumococci carried in the community are MDR. Despite wide disparities in population demographics between ViPP and SOAR, the non-susceptibility rates for several antibiotics were comparable. Thus, with some qualification, hospital antibiotic susceptibility testing data in Vietnam can inform circulating pneumococcal antibiotic non-susceptibility in young children, the group at highest risk of pneumococcal disease, to guide antibiotic prescribing and support surveillance strategies.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Dai VTT, Beissbarth J, Thanh PV, et al. Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam. J Antimicrob Chemother. 2020. PMID: 32728698. doi:10.1093/jac/dkaa276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。